Pasar al contenido principal

New biotechnological approaches to understand cancer, early animal development and human diseases

RYC-2017-23041

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD PABLO DE OLAVIDE, DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Brd4 and P300 Confer Transcriptional Competency during Zygotic Genome Activation

  • Chan, Shun Hang
  • Tang, Yin
  • Miao, Liyun
  • Darwich-Codore, Hiba
  • Vejnar, Charles E.
  • Beaudoin, Jean-Denis
  • Musaev, Damir
  • Fernandez, Juan P.
  • Benitez, Maria D.J.
  • Bazzini, Ariel A.
  • Moreno-Mateos, Miguel A.
  • Giraldez, Antonio J.
The awakening of the genome after fertilization is a cornerstone of animal development. However, the mechanisms that activate the silent genome after fertilization are poorly understood. Here, we show that transcriptional competency is regulated by Brd4- and P300-dependent histone acetylation in zebrafish. Live imaging of transcription revealed that genome activation, beginning at the miR-430 locus, is gradual and stochastic. We show that genome activation does not require slowdown of the cell cycle and is regulated through the translation of maternally inherited mRNAs. Among these, the enhancer regulators P300 and Brd4 can prematurely activate transcription and restore transcriptional competency when maternal mRNA translation is blocked, whereas inhibition of histone acetylation blocks genome activation. We conclude that P300 and Brd4 are sufficient to trigger genome-wide transcriptional competency by regulating histone acetylation on the first zygotic genes in zebrafish. This mechanism is critical for initiating zygotic development and developmental reprogramming., This research was supported by the Fonds de Recherche du Québec Santé (postdoctoral fellowship to J.-D.B.), the Surdna Foundation and the Yale Genetics Venture Fund (postdoctoral fellowship to L.M.), and the NIH (grants R01 HD074078, GM103789, GM102251, GM101108, GM081602, R35 GM122580, and 4DNucleome program to A.J.G.). M.A.M.-M. was supported by Programa de Movilidad en Areas de Investigación priorizadas por la Consejería de Igualdad, Salud y Políticas Sociales de la Junta de Andalucía and is currently supported by Ramon y Cajal program from Ministerio de Ciencia, Innovación y Universidades of the Spanish government (RYC-2017-23041). The Giraldez lab is supported by the Howard Hughes Medical Institute Faculty Scholar program and was supported by the Pew Scholars Program in the Biomedical Sciences, March of Dimes 1-FY12-230, the Yale Scholars Program, and Whitman fellowship funds provided by E.E. Just, Lucy B. Lemann, Evelyn and Melvin Spiegel, The Haldan Keffer Hartline and Edward F. MacNichol, Jr., of the Marine Biological Laboratory in Woods Hole, Massachusetts to A.J.G.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish

  • Moreno-Sánchez, Ismael
  • Hernández-Huertas, Luis
  • Nahón-Cano, Daniel
  • Martínez-García, Pedro Manuel
  • Treichel, Anthony J.
  • Gómez-Marín, Carlos
  • Tomás-Gallardo, Laura
  • Silva Pescador, Gabriel da
  • Kushawah, Gopal
  • Egidy, Rhonda
  • Perera, Anoja
  • Díaz Moscoso, Alejandro
  • Cano-Ruiz, Alejandra
  • Walker, John A.
  • Muñoz-Ruiz, Manuel Jesús
  • Holden, Kevin
  • Galcerán, Joan
  • Nieto, M. Ángela
  • Bazzini, Ariel A.
  • Moreno Mateos, Miguel Ángel
CRISPR-Cas13 RNA-targeting systems are widely used in basic and applied sciences. However, its application has recently generated controversy due to collateral activity in mammalian cells and mouse models. Moreover, its competence could be improved in vivo. Here, we optimized transient formulations as ribonucleoprotein complexes or mRNA-gRNA combinations to enhance the CRISPR-RfxCas13d system in zebrafish. We i) use chemically modified gRNAs to allow more penetrant loss-of-function phenotypes, ii) improve nuclear RNA targeting, and iii) compare different computational models and determine the most accurate to predict gRNA activity in vivo. Furthermore, we demonstrate that transient CRISPR-RfxCas13d can effectively deplete endogenous mRNAs in zebrafish embryos without inducing collateral effects, except when targeting extremely abundant and ectopic RNAs. Finally, we implement alternative RNA-targeting CRISPR-Cas systems such as CRISPR-Cas7-11 and CRISPR-DjCas13d. Altogether, these findings contribute to CRISPR-Cas technology optimization for RNA targeting in zebrafish through transient approaches and assist in the progression of in vivo applications., We thank all members of the Moreno-Mateos laboratory for their intellectual and technical support. This work was supported by Ramon y Cajal (RyC-2017-23041), PID2021-127535NB-I00, CNS2022-135564 and CEX2020-001088-M grants funded by MICIU/AEI/ 10.13039/501100011033 by “ERDF A way of making Europe” (“ERDF/EU”), and by ESF Investing in your future from Ministerio de Ciencia, Innovación y Universidades and European Union (M.A.M.-M.). This work has also been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU (PRTR-C17.I1) and the Regional Ministry of University, Research, and Innovation of the Autonomous Community of Andalusia within the framework of the Biotechnology Plan applied to Health. The Moreno-Mateos lab was also funded by the European Regional Development Fund (FEDER 80% of the total funding) by the Ministry of Economy, Knowledge, Business and University, of the Government of Andalusia, within the framework of the FEDER Andalusia 2014-2020 operational program within the objective “Promotion and generation of frontier knowledge and knowledge oriented to the challenges of society, development of emerging technologies (grant UPO-1380590)” and by the Fondo Europeo de Desarrollo Regional (FEDER) and Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía, within the operative program FEDER Andalucía 2014-2020 (01—Refuerzo de la investigación, el desarrollo tecnológico y la innovación, grant P20_00866). M.A.M.-M. was the recipient of the Genome Engineer Innovation 2019 Grant from Synthego. The CABD is an institution funded by University Pablo de Olavide, Consejo Superior de Investigaciones Científicas (CSIC), and Junta de Andalucía. I.M-S. was a recipient of the Margarita Salas Postdoctoral contract funded by “NextGenerationEU”, Plan de Recuperación, Transformación y Resilencia and Ministerio de Ciencia, Innovación y Universidades (recualificación del sistema universitario español 2021-2023, Pablo de Olavide University Call). L.H-H. and D.N-C. were recipients of Ayudas para contratos predoctorales para la formación de doctores (Ministerio de Ciencia e Innovación) funded by MICIU/AEI /10.13039/501100011033 and FSE invierte en tu futuro and FSE. C.G-M. was funded with Ayudas captación, incorporación y movilidad de capital humano de I+D+i, Junta de Andalucía (POSTDOC 21_00667). P.M.M.G. was funded by a postdoctoral fellowship from Junta de Andalucía (DOC_00397). This study was supported by the Stowers Institute for Medical Research. A.A.B. was awarded a US National Institutes of Health grant (NIH-R01 GM136849 and NIH R21OD034161). A.J.T. was supported by the US National Institute of Health: F31HD110268. This work was completed as part of thesis research for A.J.T. and G.dS.P., Graduate School of the Stowers Institute for Medical Research. This work was supported by grant PID2021-125682NB-I00 to M.A.N. funded by MICIU/AEI /10.13039/501100011033 and by FEDER, UE; funds were also provided by Instituto de Salud Carlos III (CIBERER, CB19/07/00038 to M.A.N.) and Generalitat Valenciana (Prometeo 2021/45). M.A.N. also acknowledges financial support from the Spanish State Research Agency, through the “Severo Ochoa Program” for Centres of Excellence in R&D Grant CEX2021-001165-S funded by MCIN/AEI/ 10.13039/501100011033. M.J.M. was supported by grant PID2020-120463RB-I00 funded by the Spanish Ministerio de Ciencia e Innovación. We thank our colleague Francisco J. Guerra (Stowers Institute and CABD) for the initial research on Cas7-11, Amanda Lawlor and Kate Hall (Stowers Institute) for their technical work on RNA sequencing, and Cielo Centola for the help with illustrations (CABD)., With funding from the Spanish government through the "María de Maeztu Unit of Excellence" accreditation (CEX2020-001088-M)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S)., Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Peces - Peces de agua dulce., Embriones no protegidos por la ley - Embriones de Peces. Danio, Orycias